Notably, mutations in MLL4 have been associated with both early clone formation in normal epithelial tissues (10–12), as well as with aggressive and metastatic forms of cutaneous SCC (cSCC) (13–15), the second most common of all human malignancies (16). Here, KMT2D is linked to skin squamous cell carcinoma.